| Date | Document |
|---|---|
| 21/12/2012 | Newsletter-December 2012 |
| 21/12/2012 | Fibrosis Update |
| 15/11/2012 | Results of Annual General Meeting |
| 15/11/2012 | AGM Presentation to Shareholders |
| 07/11/2012 | FerriScan gains ground with US Insurance Payers |
| 31/10/2012 | Appendix 4C - quarterly |
| 23/10/2012 | FerriScan contracted for two new Clinical Trials |
| 18/10/2012 | FDA requests a broader Indication for Use for Ferriscan |
| 15/10/2012 | Annual Report to shareholders |
| 15/10/2012 | Notice of Annual General Meeting Proxy Form |
| 15/10/2012 | Notice of Annual General Meeting/Proxy Form |
| 28/09/2012 | Full Year Statutory Accounts |
| 31/08/2012 | Preliminary Final Report |
| 31/07/2012 | Appendix 4C - quarterly |
| 11/07/2012 | FDA Submission for HepaFat Scan & update Liver Fibrosis Test |
| 30/04/2012 | Appendix 4C - quarterly |
| 05/04/2012 | Update on HepaFat Scan and Liver Fibrosis Test |
| 19/03/2012 | Company Secretary Appointment/Resignation |
| 29/02/2012 | Half Yearly Report and Accounts |
| 31/01/2012 | Appendix 4C - quarterly |